Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e01923 | Publicado em: 11/05/2023. Vigilância Sanitária em Debate , "Rio de Janeiro, Brasil", v. 11, p. 1–10, 2023. DOI: 10.22239/2317-269x.01923. Disponível em: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1923. Acesso em: 4 abr. 2025.